By Toi Degree N.C. Cooperative Extension As winter settles in and daylight hours shrink, millions of Americans are grappling ...

A new medical large language model (LLM) achieved over 91% accuracy in identifying female participants diagnosed with major ...

The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under physician oversight.

FDA approves first brain stimulation device for home depression treatment. Flow Neuroscience's FL-100 headset uses electrical ...

A new genetic and clinical analysis suggests that atypical depression represents a distinct biological subtype of the ...

The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder. Rejoyn, made by Otsuka Pharmaceutical and Click Therapeutics, ...

A new medical large language model (LLM) achieved over 91 percent accuracy in identifying female participants diagnosed with ...

The American College of Lifestyle Medicine, or ACLM, released a new expert consensus statement on the role of lifestyle ...

Intra-Cellular Therapies’ surging antipsychotic Caplyta has scored again with remarkable trial results, fueling its bid for a third and potentially most lucrative indication—major depressive disorder ...

The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...

A research team at Université Laval may have discovered why physical exercise and living in favorable socioeconomic ...